Escolar Documentos
Profissional Documentos
Cultura Documentos
I.
INDUSTRY:
OVERVIEW
COSMETICS - >$300B GREENVILLE, SC
FUNDING SOUGHT:
II.
PROBLEM
Primal , universal desire to maintain youthful appearance Natural function of aging, sun exposure, gravity Natural degeneration, loss of skin elastin production over time
Elastin is a tissue rubber band that keeps it tight. With age it degrades and not restored
3
III.
ConnecTiss SOLUTION
IV.
VALUE PROPOSITION
VI.
MARKET
COSMECUTICALS
Cosmetics that purportedly deliver medicinal or drug-like benefits Large growing market: $31B (worldwide); $10B (US); +7%/yr
(GBI Research, 2013)
ConnecTiss target market Skincare cosmecuticals ~43% market Europe (5 countries), US dominate; huge potential in China, India & Japan Not recognized, regulated by FDA (claims monitored by FTC) Highly fragmented; low barriers to entry Consumers, dermatologists overwhelmed by # products, product claims Product info often not scientifically sound, clinically proven
6
VII.
COMPETITION
MAJOR COMPANIES
(>400 mfgers, suppliers)
COSMECUTICALS
MAJOR BRANDS
ConnecTiss
YES ? YES TBD
Therapeutic Effects in
Side Effects
6-24 wks
Skin irritation, burning
? ?
IX.
TEAM
Twenty-six years bus experiences in life sciences , incl. SVP-CIBA Vision/Novartis, CEO of 3Ti, Refocus Group & Cambium Medical Technologies; Pres, COO Oncose. Director of VirtualScopics since 2005 (NASDAQ:VSCP) & Metaclipse since 2013. Experiences w/ 13+ medial start-ups. Took 2 start-ups public; 3 subsequently acquired by industry leaders/strategic investor. Raised $60M+ in start-up financing. 1971-88 in consumer packaged goods marketing - Unilever, General Foods & Hanes Corp. BS-Indiana; MBA-Notre Dame.
Hunter Endowed Chair, Professor of Bioengineering and Director of NIH-funded SC Center for Biomaterials and Tissue Regeneration, Clemson University. Research interests include extracellular matrix, heart valve and elastin. Inventor, co-inventor of 13 patents. Author, co-author of over 5 book Chapters & 100+ refereed-journal publications. Fellow, American Institute of Medical & Biological Engineering. Clemson awards for faculty excellence and outstanding research achievements. Prior Professors at University of Pennsylvania School of Medicine and University of Michigan. PhD-University of Pune (India).
KEY MILESTONES:
Proof of concept in animal models, related publications 1 issued, 2 filed patents Founders funding to date License option pending w/ CURF CEO on board late 2013
XII.
FUNDING
SEEKING:
First outside financing (500K)
USE OF PROCEEDS:
Secure Clemson license option Prototype formulation development Initial skin absorption studies Business Plan Next round funding
10
2016 Q1 $2.0M Q2 Q3 Q4
Stability Studies
Packaging Dev. Clinical Trials Contract Mfg. Commercial x
Ph-I
Ph-II
Ph-III
11
OTC
Rx
2015
2016
2017
2018
2019
$28,564 -
$47,085 -
$0.0
$0.45 ($0.45) ($0.45)
$381
$2,450 ($2,069) ($2,200)
$2,591
$4,278 ($451) ($739)
$8,700
$7,380 $1,320 $592
$21,423
$16,710 $4,713 $2,428
$35,314
$25,897 $9,417 $5,183
* $0.05
$0.05 $0.476
$0.476 $0.789
$0.789 $2,109
$2,109 $4,922
$4,9 $9,272
EMPLOYEES
PRE-MONEY VALUATION
2
$2.0M
16
$4.5M
25
$7M
35
$23M
76
$57M
108
$94M
12
SUMMARY
STRONG CORE, COLLABORATIVE TEAM
Proof of concept est in animal models, cardiology Strong IP (1 issued, 2 pending patents, several publications)
Thank you!
13